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heart cycle; myoglobin; nuclear magnetic resonance; oxygen; phosphate metabolism THE MYOCARDIUM TIGHTLY regulates O 2 consumption to meet the constant energy demand of its contractile activity. Such a coupling of chemical and mechanical energy is essential in maintaining normal physiological function and is mediated, in part, by the creatine kinase reaction, which buffers ATP loss. Although steady-state measurements have established the presence of metabolic and vascular controls, they do not elucidate the regulatory mechanism during a contraction. The energy demand is certainly not constant but peaks during contraction and falls during the relaxation phase. Observing only the energy balance at steady state may then overlook metabolic oscillations and the associated biochemical regulation on a transient time scale. Indeed, optical studies have shown an oscillatory behavior in both NADH and oxymyoglobin (MbO 2 ), during the contraction cycle (14, 29) . Given the optical findings, phosphate metabolite levels may also fluctuate during a heart cycle.
Indeed, the question has attracted the attention of investigators. Several studies have focused on assessing whether the high-energy phosphate metabolites actually fluctuate during a heart cycle. The results, however, are conflicting. In one study, the PCr level falls with the systole and rises with the diastole in isolated, glucose-perfused hearts (11, 30) , whereas in another study the metabolic levels are unperturbed in either pyruvate-perfused or in situ myocardium (15, 18, 22, 30) .
Although optical studies have detected a fluctuation in MbO 2 saturation within a heart cycle, this observation has so far been inconsistent. A study of perfused hearts reported an increasing MbO 2 saturation during systole, whereas another study noted that cellular PO 2 actually drops during systole (14, 29) . Still others have observed no change (10, 25) . To our knowledge, no nonoptical measurements so far have confirmed any fluctuation in the cellular O 2 level. A rise in cellular PO 2 during systole is certainly consistent with the observed steady-state rise in MbO 2 saturation during increased myocardial oxygen consumption (MV O 2 ) (16). However, if both the MbO 2 saturation and the phosphate metabolite levels remain constant then neither ADP nor O 2 plays any significant role in modulating mitochondrial energy production during a heart contraction cycle, and this raises questions about their role in regulating MV O 2 . That observation would help narrow the research focus on the regulatory molecules, such as NADH or Ca 2ϩ .
Measuring the transient alteration in either MbO 2 or high-energy phosphate levels, however, poses a technical challenge. Unless the experiments include stringent precautions, these measurements confront many artifactual errors. A recent study (7) presented a gated NMR technique with sufficient time resolution to observe the energetic changes during a contraction cycle in the rat gastrocnemius muscle in vivo. Indeed, the technique has demonstrated that PCr levels fall rapidly within 16 ms after stimulation and recover during the relaxation phase. The P i signal rises stoichiometrically, while the ATP signal remains constant. The data suggest that PCr hydrolysis yields substantial energy for skeletal muscle contraction, much more than previously reported in freeze-clamp experiments, which have a time resolution of ϳ100 ms. Such a technique is then applicable in determining the transient highenergy phosphate level changes in myocardium. Moreover, because 1 H NMR methods can now detect the intracellular Mb signal (23) , the opportunity also exists to determine whether cellular O 2 itself is dynamically changing during a heart cycle.
We have focused on the transient response of MbO 2 and high-energy phosphate metabolites during a heart contraction cycle and under enhanced workstates. Even though the steady-state level of intracellular O 2 declines as the MV O 2 increases, along with the PCr level, neither cellular O 2 nor PCr levels fluctuate throughout the entire cardiac cycle at different workstates. An infusion of either pyruvate or glucose to shift the availability of NADH for oxidative phosphorylation produces the same results. The observations imply that the metabolic regulatory mechanism during a cardiac contraction is not related to either O 2 or ADP and that any transient energetic changes are undetectable. The results also confirm the utility of the gated NMR technique to examine the interplay between metabolic energy and force development to develop a deeper understanding of the cellular mechanisms governing the fundamental unit of myocardial contraction.
METHODS
Animal preparation and heart perfusion. Rat heart perfusion at 37°C has been previously described in detail (8) . After pentobarbital anesthesia (60 mg/kg) and heparinization (1,000 U/kg body wt) of male Sprague-Dawley rats (350-400 g), the hearts were quickly isolated and perfused with a modified Langendorff system. A peristaltic pump (Rainin Rabbit) maintained a constant, nonrecirculating perfusion rate of 18 ml/min. The perfusion medium was a modified KrebsHenseleit buffer containing (in mM) 118 NaCl, 4.7 KCl, 1.2 KH 2 PO 4 , 1.8 CaCl 2 , 20 NaHCO 3 , 1.2 MgSO 4 , and 15 glucose. The perfusate was passed through both 5-and 0.45-µm Millipore filters, saturated with 95% O 2 -5% CO 2 and pH maintained at 7.4 Ϯ 0.05. The heart was bathed in perfusate flowing from the pulmonary artery. The heart was placed in a 20-mm NMR tube and isolated with a Teflon plug with holes to permit perfusate overflow.
A saline-filled latex balloon inserted in the left ventricle was used to monitor the heart rate (HR) and left ventricular pressure (LVP) via a strain gauge transducer (Statham P23 XL) connected to an oscillographic recorder (Gould RS 3200 or Windograf). The balloon volume was adjusted to give an end-diastolic pressure of 6-8 mmHg. Hearts were paced with a bipolar platinum electrode connected to the Grass S48 stimulator. Rate-pressure products (RPP) were calculated from HR times the left ventricular developed pressure (LVDP). Perfusion pressure was monitored via saline-filled polyethylene tubing connecting the aortic cannula to a second strain gauge transducer (Statham P23 XL).
Four different perfusion conditions were used for the transient measurements of cellular O 2 and phosphate metabolite levels (Table 1) . For all the experiments, the perturbation followed the control period, during which the hearts were perfused with the fully O 2 -saturated perfusate and paced at 300 beats/min. In protocol I we used the control perfusion condition with 15 mM glucose throughout the entire experiment. In protocol II we used conditions in which hearts were stimulated to a high workload by pacing at 600 beats/min and infusing 80 ng/ml dobutamine (Abbott Laboratories). In protocol III we introduced hypoxic conditions to 300 beats/min paced hearts. In protocol IV we used 10 mM pyruvate/10 mM glucose as substrates to produce a nonlimiting NADH condition (13) .
Perfusate O 2 , lactate, and Mb measurement. A polyethylene catheter, inserted close to the pulmonary artery, was used to withdraw ϳ50% of the perfusate flowing from the heart. A Yellow Springs Instrument 5300 meter was used to monitor the perfusate O 2 concentration in a temperature-jacketed chamber. The remaining 50% of the perfusate exited the chamber above the Teflon plug as an overflow. Parallel bench experiments empirically determined the O 2 loss in the tubing and adjusted the measured PO 2 value to reflect the venous value proximal to the heart (6). MV O 2 was calculated from the corrected inflow and outflow O 2 measurements and the perfusion flow rate.
A YSI 2700 Bioanalyzer determined the perfusate lactate concentration. Samples were measured in triplicate, and the measurement linearity was assessed by two-point calibration at 5 and 28 mM lactate concentrations. Sensitivity of the measurement reached 0.01 mM lactate. The membrane current settled at Ͻ2 nA before sample measurements were initiated (8) . Mb loss from the perfused heart was determined by optically measuring the perfusate sample at 540 nm after converting Mb to MbCN.
NMR. An AMX 400-MHz Bruker spectrometer was used to record 1 (6, 23) . The 1 H 90°pulse was 65 µs, calibrated against the perfusate H 2 O signal. Observing the MbO 2 signal required a 40-ms acquisition time and a 45°pulse angle. The spectral width was set at 8,065 Hz; the data size was 512 words. Six thousand transients were averaged for a typical 1 H spectrum, requiring 5 min of signal accumulation. The free induction decays (FID) were zero-filled to 2K and multiplied by an exponential-Gaussian window function. A spline fit then smoothed the baseline. All spectral lines were referenced as 4.67 ppm at 36°C, which was in turn calibrated against sodium-3-(trimethylsilyl)propionate-2,2,3,3-d 4 .
For the 31 P spectra, a typical control spectrum used a 45°p ulse angle, a 0.5-s repetition time, and 256 scans/block (2.2 min). The 31 P 90°pulse was 72 µs, calibrated against a 0.1 M phosphate solution. Spectral width was set at 6,494 Hz; the data size was 4K. FIDs were zero-filled to 8K and apodized with an exponential-Gaussian function to better resolve intracellular P i signal. The 31 P signals were referenced to phosphocreatine (PCr) as 0 ppm. Gated 31 P and 1 H NMR measurement during a contraction cycle. Gated 31 P acquisition was described previously (7). On heart stimulation, a home-built gating device sampled the 5-10 Hz output pulse and inserted a defined delay with Ͻ1-ms resolution before sending a pulse to trigger the NMR signal acquisition. Synchronization of the triggering pulses with the specific phases of the heart contraction cycle was visualized with a Tektronix 2230 digital oscilloscope. Signal averaging then occurred at each defined time point distal to the stimulation pulse and with a constant relaxation delay. The timing diagram is illustrated below. 
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A delay, t1, distal to the heart stimulation, A, elapsed before a signal gated the spectrometer, time point B, to acquire an NMR signal. For each subsequent data block, t1 was incremented stepwise from 5 ms up to 190 ms. The time interval between B and C corresponds to the acquisition time, which is constant throughout all the experiments. A final time interval t2 was inserted to maintain the relationship (t1 ϩ Acq ϩ t2) ϭ 0.4 s. Therefore, for the hearts paced at 300 beats/min, the 31 P signals were acquired every other beat. For the hearts paced at 600 beats/min, 31 P signals were acquired at 1 every 4 beats. A signal-averaged 31 PCr, P i , and ATP levels were determined from integrated areas of PCr, P i , and ␤-ATP signals, respectively. Saturation factor corrections were not made when comparing the phosphagen signals from different cardiac workloads and from different phases of heart cycle, because previous relaxation measurements revealed no significant changes in longitudinal relaxation time (T1) over a wide range of cardiac performances (4). The chemical shift of P i peak reflects the intracellular pH and was estimated from the equation pH ϭ pK ϩ log 1
where pK ϭ 6.9, ␦ A ϭ ␦ppm of [H 2 PO 4 ] Ϫ1 at 3.290 ppm, ␦ B ϭ ␦ppm of [HPO 4 ] Ϫ2 at 5.805, and ␦ 0 ϭ ␦ppm of observed P i peak referenced to PCr ␦ppm as 0 ppm.
Curve fitting and statistical analysis. Linear regression analysis, using least squares method (Sigma Plot, Jandel Scientific) determined the correlation coefficient, slope, and intercept. Errors are expressed as Ϯ SD. Student's t-test indicated a statistical significance when P Ͻ 0.05. Figure 1 shows the nongated steady-state 1 H and 31 P spectra from the perfused myocardium under different pacing conditions. In control hearts paced at 300 beats/min (workstate I), the 1 H NMR signal of the Mb Val E11 and 31 P signal intensities are identical to the intensities observed in spontaneously beating hearts (Fig. 1 , A: spectrum a and B: spectrum aЈ). Typical control (workstate I) RPP and MV O 2 were 29,337 Ϯ 2,076 mmHg/min and 32.4 Ϯ 2.0 µmol · min Ϫ1 · g dry wt Ϫ1 , respectively. As the electrical stimulation increases the HR to 450 beats/min (workstate II), no changes are noted in the MbO 2 and phosphate metabolite signals, even though RPP has increased by 22% and MV O 2 by 16% (Fig. 1 , A: spectrum b and B: spectrum bЈ). Paced at 600 beats/min and infused with 80 ng/ml dobutamine (workstate III), the heart increases its MV O 2 by 56% and RPP by 83% ( Table 2 ). The MbO 2 signal intensity now decreases by 15%, while PCr declines by 9% (Fig. 1A : spectrum c and B: spectrum cЈ). As soon as the HR resumes 300 beats/min, the 1 H MbO 2 signal recovers fully (Fig. 1, A:  spectrum d) . The PCr signal, however, overshoots transiently to 123%, before it recovers to the control level (Fig. 1, B: spectrum dЈ). In contrast, P i undershoots initially to 65% of control level. In all workstates ATP level and pH remain constant, even though the lactate concentration has increased at high workload. The graphical analysis of MbO 2 saturation and PCr level versus O 2 consumption is shown in Fig. 2 . A linear regression of the graph shows that every 10% increase in MV O 2 is accompanied by a 2.9% decrease in Mb oxygenation.
RESULTS

Steady-state response to increased workload.
Transient PO 2 and high-energy phosphate metabolite changes during a heart cycle. The experimental protocol to examine transient metabolite fluctuations within a heart cycle involves four different conditions as described in the METHODS section and in Table 1 . Protocol I uses glucose perfusion and a HR of 300 beats/min. The PCr, P i , and MbO 2 response is shown in Fig. 3 . Intracellular O 2 level and high-energy phosphate levels remain unchanged throughout the entire heart cycle. ATP level and intracellular pH are also unchanged (data not shown).
In protocol II the increased heart workload enhances the energy demand between systole and diastole. At 600 beats/min and with 80 ng/ml dobutamine, the heart increases its RPP to 196% and its MV O 2 to 156% above the corresponding control levels. Even though at this workload, the steady-state MbO 2 saturation drops by 15%, while PCr decreases by 6% and P i increases by 83%, no transient changes in either intracellular oxygenation or phosphate metabolite levels are observed (Fig. 4) .
When the perfused hearts are challenged with hypoxic conditions (protocol III), MbO 2 saturation drops to 36% of the fully oxygenated state, and PCr level decreases to 62% of the normoxic level. Intracellular acidification is significant (pH ϭ 7.03). RPP and MV O 2 drop to 52.0 Ϯ 2.4 and 47.5 Ϯ 4.0% of the normoxic control values, respectively. The hypoxic manipulation, however, still does not produce any fluctuations in intracellular O 2 or phosphate metabolite levels throughout the entire heart contraction cycle (Fig. 5) .
Protocol IV is similar to protocol I, except that 10 mM pyruvate is infused in addition to 10 mM glucose. Pyruvate causes the steady-state PCr-to-P i ratio to increase significantly, an order of magnitude higher Values are means Ϯ SD; n ϭ 11 hearts. At beginning of each heart perfusion, hearts were paced at 300 beats/min for 30 min (workstate I ). During this period, typical rate-pressure product (RPP) was 29,337 Ϯ 2,076 mmHg/min and myocardial oxygen consumption MV O 2 was 32.4 Ϯ 2.0 µmol Ϫ1 ·min Ϫ1 ·g dry wt Ϫ1 . Hearts were subsequently paced at 450 beats/min (workstate II ), and 600 beats/min with 80 ng/ml dobutamine infusion (workstate III ). RPP, MV O 2 , MbO 2 , phosphocreatine (PCr), ATP, and P i values are expressed as % of levels measured during workstate I. Lactate production rate is expressed in µmol · min Ϫ1 ·g dry wt Ϫ1 . [PO 2 ] 50 of 3.8 mmHg was used for the calculation of intracellular PO 2 . Significantly different from workstate I (Student's t test) * P Ͻ 0.05, † P Յ 0.001). ‡ Calculated value of intracellular PO 2 at 100% MbO 2 saturation is indeterminate. Fig. 2 . Graph of MbO 2 (r) and PCr (k) as a function of O 2 consumption. As O 2 consumption increases with electrical and inotropic stimulation, MbO 2 and PCr levels decline. As workstate steps from I to III, MV O 2 increases by 56%. MbO 2 level decreases to 85% and PCr to 91% of control. Fig. 3 . PCr, P i , and MbO 2 levels during a heart contraction cycle (protocol I, 300 beats/min). PCr (r) and MbO 2 (n) signals are normalized to intensities observed at peak systole (115 ms time point). P i (j) signal intensity is normalized to PCr signal intensity. No significant changes in levels of these metabolites are observed throughout entire heart cycle. X-axis of graph showing 5-, 75-, 115-, 135-, 160-, and 190-ms time points corresponds respectively to mid-diastolic, end-diastolic, peak-systolic, mid-systolic, end-systolic, and second diastolic phase of heart cycle. above the glucose control level, which is consistent with previous reports (13) . However, the addition of 10 mM pyruvate still does not produce any transient changes in either the MbO 2 or the high-energy phosphate signals (Fig. 6 ).
DISCUSSION
Regulation of MV O 2 .
How MV O 2 accommodates the changing energy demand of cardiac work is still a question under intense debate. Early studies of isolated mitochondria indicate that ADP is a key regulatory molecule, linking myosin ATP hydrolysis and mitochondrial ATP production thereby maintaining a cellular energy balance (5). Indeed, some perfused-heart experiments have lent support to the paradigm. As the myocardial workstate increases, the 31 P NMR signal of PCr declines, reflecting an increase in ADP (4). Others, however, have only observed a transient drop in PCr at the onset of high workload, which gradually returns to the control level (26) .
These conflicting observations from perfused-heart studies raise questions about the role of ADP as the regulator of myocardial respiration in vivo. Certainly the available substrate can modulate the ADP dependence. With pyruvate as the substrate, the NADH level is not limiting, and ADP maintains a simple MichaelisMenten relationship with MV O 2 (12, 13) . Fatty acid substrates in addition to 10 mM glucose can also induce an NADH excess but an ADP-limited metabolic profile (13) . With glucose as the substrate, however, NADH does become limiting, and ADP no longer shows any relationship with MV O 2 . Therefore, in the glucose-perfused heart, carbon substrate delivery to the mitochondria, not ADP, is limiting O 2 consumption (12, 13, 19) . In vivo myocardium experiments have raised more challenges. As work output and O 2 consumption increase, the 31 P NMR spectra show no sign that ADP concentration is altered. These observations suggest that ADP might not be the only regulator of oxidative phosphorylation in myocardium in vivo (3, 28) .
The ADP independent regulation of MV O 2 in the in vivo and the glucose-perfused heart has led researchers to postulate that these models are similar. Our study shows that as the myocardial work is raised from the basal state to workstate II, the 16% increase in MV O 2 does not elicit any steady-state changes in the phosphate metabolite levels. Even at the workstate III, the Fig. 4 . PCr, P i , and MbO 2 levels during a heart contraction cycle at high workload (protocol II, 600 beats/min). PCr (r) and MbO 2 (n) signals are normalized to signal intensities observed during 300 beats/min pacing. Steady-state levels of both PCr and MbO 2 have declined from level observed at 300 beats/min pacing. P i (k) signal intensities are normalized to PCr signal intensities. No changes in Mb or phosphate metabolite levels are noted throughout cardiac cycle. X-axis of graph showing 3-, 20-, 35-, 50-, 70-ms time points corresponds respectively to end-diastolic, midsystolic, peak systolic, midsystolic, and end-systolic phase of heart cycle. Fig. 5 . PCr, P i , and MbO 2 levels during a heart contraction cycle with hypoxia (protocol III, 300 beats/min and hypoxia). Perfusate equilibrated with 20% O 2 -80% N 2 decreases level of MbO 2 (n) to 36% and PCr (r) to 62% of control. PCr and MbO 2 signals are normalized to normoxic signal intensities. P i (j) signal intensities are normalized to PCr signals. Even with a pronounced cellular hypoxia, Mb and phosphate metabolite levels still do not fluctuate over a heart cycle. X-axis notation for heart cycle timing is same as for Fig. 3 . Fig. 6 . PCr, P i , and MbO 2 levels during a heart contraction cycle with pyruvate (protocol IV, 300 beats/min and pyruvate/glucose). PCr (r) and MbO 2 (n) signals are normalized against signal intensities at peak systole (115 ms time point). P i (j) signal intensities are normalized to PCr signal. Again, no heart cycle-dependent fluctuations of these metabolite levels are noticeable. X-axis notation for heart cycle timing is the same as for Fig. 3 . marked increase in MV O 2 produces only a modest, transient alteration in the PCr and P i signals. Both signals recover their control intensities within 15 min. Given this observation, ADP does not appear to be the regulator of O 2 consumption in the glucose-perfused myocardium, which is in agreement with previous reports (12, 13, 19) .
Steady-state phosphate responses to high workload. Nevertheless, at workstate III, the PCr signal intensity decreases initially and then recovers fully to the control levels within 15-20 min. Other perfused heart studies have also reported a similar PCr time course with inotropic stimulations and have ascribed the observation to a transient mismatch between the O 2 supply and demand at the onset of the high workload (26) . However, our data indicate that hypoxia is not the cause for the temporary PCr drop, because the cellular O 2 level remains constant throughout the entire high-workload period. Although MbO 2 saturation level drops promptly to 85% of control at workstate III, it remains at that level as the PCr level declines and recovers, showing that the PCr response is not associated with the intracellular O 2 level nor MV O 2 .
The drop in MbO 2 signal induced by workstate III reflects a mild functional hypoxia as the myocardium responds to a high-workload challenge. As expected for hypoxia, the glycolytic activity should increase to supplement the deficiency in oxidative ATP formation. Indeed, the lactate formation rate is elevated at high workstates and matches the observed lactate production rate in spontaneously beating myocardium subjected to hypoxemic perfusate (6) . Despite the increased glycolytic flux, myocardial acidification is not observed, consistent with other findings (9, 20) , and stands in sharp contrast with the skeletal muscle response during increased exercise intensity, which shows significant changes in phosphate levels and pH (24) . The changes in cellular O 2 , glycolytic flux, and pH cannot account for the temporary fall and rise of the PCr level at the onset of high workload.
Steady-state O 2 response to high workload. At high workloads the heart consumes more O 2 , and convective and/or diffusive flow must enhance the O 2 delivery. Unlike the in situ myocardium, the constant flow perfused myocardium does not have a significant capacity to autoregulate the coronary flow. Instead, it must rely on a drop in cellular PO 2 to increase the O 2 gradient between the capillary and cytosol. That gradient alteration should enhance the diffusion driving force for O 2 delivery. Indeed, MbO 2 desaturation reflects such a shift in the O 2 gradient, which increases with MV O 2 . Within 5 min after the onset of high myocardial workload, the intracellular PO 2 reaches a steady level and adjusts the O 2 flux to meet the enhanced demand. As the workload of the heart increases from workstate II to workstate III, intracellular PO 2 drops from 142 mmHg to 22 mmHg. If the perfusate venous PO 2 approximates the mean end-capillary PO 2 Transient phosphate metabolite response during a heart cycle. During a myocardial contraction cycle, the energy demand should presumably rise and fall. Indeed, optical studies have detected oscillatory behavior in both NADH and MbO 2 , and these studies imply that the high-energy phosphate metabolite level may also fluctuate during a cardiac cycle (14, 29) . Several researchers have investigated whether the phosphate metabolite levels fluctuate during a cardiac cycle but have produced conflicting results. In glucose-perfused but not in pyruvate-or acetate-perfused myocardium, the PCr level dips at systole and rises at diastole (11, 30) . In an isolated working heart the fluctuation is even more pronounced than in the Langendorff-perfused heart, arising presumably from the 28% increase in MV O 2 and the higher P i -to-ATP ratio (P i /ATP) (17, 30) . In contrast, in situ myocardium experiments have failed to detect any fluctuation in the PCr signal, and the results have led to the hypothesis that the distinct substrate and O 2 availability of the perfused and in situ heart may account for the difference (15, 18, 22) .
In a recent study of rat skeletal muscle, a gated NMR technique has achieved millisecond resolution and has monitored a significant transient drop in the PCr during a peak force development (7) . The technique, however, reveals no transient fluctuation in any highenergy phosphate metabolite signals or MbO 2 saturation in the perfused normoxic or hypoxic myocardium with either glucose or pyruvate as the substrate. Both substrate and O 2 levels remain constant throughout the entire contraction cycle, consistent with the in situ myocardium observations. In contrast to skeletal muscle, the heart either maintains a balance between energy supply and demand or utilizes an undetectable amount of PCr during a contraction cycle. A normal rat cardiac cycle is completed in Ͻ200 ms and may therefore require a substantial glycolytic ATP contribution, because glycolytic reactions are activated much more rapidly than oxidative phosphorylation under energydemanding conditions (1). However, computer simula- tions have demonstrated that with glycolytic compensation alone, PCr should drop in response to a sudden work jump (1). Our results are consistent with the observed restoration time course of Ͻ15 s between cytosolic ATP utilization and mitochondrial ATP production (15) . A rapid replenishment of energy within a heart cycle requires then a fast increase in oxidative phosphorylation, in response to myosin ATPase activity. Indeed, the heart under a high workload can turn over its total ATP content in 1 s (27) .
The constant PCr/ATP within a heart cycle also indicates that the ADP concentration is constant throughout the heart cycle and therefore may not play a significant role in regulating any transient flux in oxidative metabolism. In vivo myocardium studies have already cast doubts on a simple kinetic control of mitochondrial oxidative phosphorylation by ADP alone and even a model involving both ADP and P i as bireactants (15, 28) .
Transient O 2 response during the heart cycle. Despite the peak energy demand and contraction ischemia during systole, some investigators have proposed that the heart might be more oxygenated during the systolic phase (21, 29) , whereas other optical measurements have shown deoxygenation during systole (14) . In fact, some optical studies have reported no systole-diastole differences in tissue O 2 levels (10, 25) . In the present study, no transient change is observed in the intracellular oxygenation within a cardiac cycle with either glucose or pyruvate as the substrate. As the workload increases to workstate III, the MV O 2 has also increased by 56%. That increase is much larger than the 28% enhancement observed in an isolated working heart relative to a Langendorff-perfused heart (30) . Although the steady-state intracellular O 2 level declines at this workstate, as indicated by 15% drop in the MbO 2 signal intensity, no cyclic alteration in the MbO 2 saturation is observed.
The relationship between the MbO 2 saturation and MV O 2 provides insight into the expected change in O 2 consumption between diastole and systole. In the steady state, the increase in MV O 2 is accompanied by a drop in MbO 2 signal intensity. The linear relationship, shown in Fig. 2 , shows that a 10% change in the MbO 2 signal corresponds to a 34% change in MV O 2 . Given the signal sensitivity, a 10% change in the MbO 2 signal intensity would certainly be detectable in the reported spectra; yet no MbO 2 change is observed. The results then imply that the ␦MV O 2 increase is Ͻ34% between the systolic and the diastolic phase of the heart cycle, consistent with the theoretical predictions that ATP consumption per each heartbeat will deplete only 2% of the total (ATP ϩ PCr) pool (31) . Additionally, the extent or the duration of any contraction-induced ischemia appears less significant than previously conceived (18, 21) .
The increased workload, however, does deplete the cellular O 2 and induces a functional hypoxia. Alternatively, decreasing the perfused O 2 also produces a supply-side hypoxia and presents another physiological condition to observe any transient change in cellular oxygenation and metabolism during a heart cycle. The hypoxic manipulation in the study (protocol III, Comparison between the in vivo and perfused heart response. In both transient and steady states, in vivo hearts fail to exhibit pronounced changes in phosphate metabolites with increased workloads (3, 15, 18, 22, 28) . The response of the isolated perfused hearts depends on the available substrate. When perfused with pyruvate, the heart shows ADP-dependent O 2 consumption in the steady state (12, 13) . On the other hand, during a heart cycle, pyruvate-perfused hearts fail to show phosphate metabolite changes and therefore no systolic dependence on ADP regulation (30) .
Glucose-perfused isolated hearts behave in an opposite manner. In the steady state, isolated hearts perfused with glucose do not change their phosphate metabolites with changing workload (12, 13, 19) . Within a heart cycle of the glucose-perfused hearts, phosphate metabolite fluctuates (11, 30) . Some researchers have noted that the in vivo myocardium resembles a glucoseperfused heart. But in the transient state, the in vivo myocardium appears to be similar to the pyruvateperfused heart model. The conflicting results then suggest that ADP regulation is different in the steady versus the transient state. However, our experimental results show that both glucose and pyruvate-perfused hearts are not dependent on ADP regulation of systolediastole variations. The transient metabolite fluctuations from perfused and in vivo myocardium within a heart cycle are now consistent.
In conclusion, the energy demand in the myocardium increases with higher workload and presumably during the systolic phase of the heart contraction cycle. At increased workloads, steady-state PCr declines initially but recovers to its control level within 15 min. Such a response does not arise from a time-dependent change in cellular oxygenation because intracellular O 2 level falls with high workloads and remains low as long as O 2 consumption is enhanced. An increase in capillaryto-cell O 2 gradient then facilitates the increased O 2 flux.
Over a heart contraction cycle, no variation in either phosphate metabolites or cellular oxygenation is measurable. In contrast to skeletal muscle, the myocardium does not show a significant change in oxidative metabolism between the systolic and diastolic phases of a heart contraction cycle.
